Stem cell storage service connected with potential Benitec HIV therapy
MELBOURNE, Australia, Aug 16. /PRNewswire-FirstCall/ -- Benitec Limited (ASX: BLT) has signed a Memorandum of Understanding with California-based CalbaTech, Inc. (OTC Bulletin Board: CLBE) to provide stem cell storage services for US HIV patients who may use the healthy adult (or "blood" or "hematopoietic") stem cells in future therapy.
Benitec has collaborated with City of Hope, a biomedical research and treatment center, in the development of a possible HIV therapeutic. This investigational HIV therapeutic creates the possibility that an adult (or "blood" or "hematopoietic") stem cell based therapeutic may be able to take the place of anti-retroviral medication. Early banking of adult (or "blood" or "hematopoietic") stem cells by HIV sufferers may be very prudent if a stem cell therapy is approved by the FDA after the conclusion of clinical trials.
This potential therapy surrounds a newly discovered possible way in which to fight HIV, the virus that causes AIDS, with genetically modified adult (or "blood" or "hematopoietic") stem cells. The potential therapeutic may emerge as the first to use specially engineered, HIV-fighting genes that are inserted into patients' own harvested adult (or "blood" or "hematopoietic") stem cells. After re-infusion into the patient, the new treatment may allow patients' bodies to produce HIV-resistant white blood cells indefinitely.
Benitec's MOU with CalbaTech would provide, in the short term, that
Benitec would receive fees for stem cell storage performed by CalbaTech's
subsidiary, TherapyStem, Inc. In the longer term, both Benitec and
CalbaTech are encouraged that this potential new therapeutic will develop
an effective HIV therapeutic that relies on healthy adult (or "blood" or
"hematopoietic") stem cells. CalbaTech believes that, in the future, as
this potential therapeutic develops, TherapyStem will be able to treat the
|SOURCE Benitec Limited; CalbaTech, Inc.|
Copyright©2007 PR Newswire.